Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.

AIDS research and human retroviruses - 1 Feb 2013

Lunar Maja M, Židovec Lepej Snježana, Abecasis Ana B, Tomažič Janez, Vidmar Ludvik, Karner Primož, Vovko Tomaž D, Pečavar Blaž, Maver Polona J, Seme Katja, Poljak Mario

Abstract excerpt

Slovenia is a small European country with a total of 547 HIV-infected individuals cumulatively reported by the end of 2011. However, the estimated incidence rate of HIV infections increased from 7.0 per million in 2003 to 26.8 per million in 2011. In this study, we assessed the prevalence of transmitted drug resistance (TDR) in the past 6 years (2005-2010) and analyzed the time trend of the proportion of men...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Homosexuality, Male

Share to Molecular Epidemiology

Share to Prevalence

Share to Slovenia

Source

Open in PubMed Open full text

Identifiers

PMID: 22860694
DOI: 10.1089/AID.2012.0152
PMCID: PMC3552160

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.PMID 22860694Read ↗

HIV-1 transmitted drug resistance in Slovenia and its impact on predicted treatment effectiveness: 2011-2016 update.Semantic proximity Read ↗

Characterization of HIV-1 subtypes and drug resistance mutations in Slovakia: update 2017-2018.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.Semantic proximity Read ↗

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia.Semantic proximity Read ↗

HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium.Semantic proximity Read ↗

Prevalence, genotype distribution, and risk factors for hepatitis C infection among HIV-infected individuals in Slovenia: a 1986-2013 update.Semantic proximity Read ↗

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.Semantic proximity Read ↗

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.Semantic proximity Read ↗

[Prevalence of transmitted drug resistance in HIV-infected treatment-naive patients in Chile].Semantic proximity Read ↗

The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.Semantic proximity Read ↗

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Semantic proximity Read ↗

Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.